ViiV Healthcare has tapped a new mind for its “PrEP Wisdom” campaign, with Tony Award-winning actor and fashion icon Jeremy ...

Novartis has confirmed a number of new cases of tumors that developed in children treated with its gene therapy Zolgensma ...

Moderna’s third quarter proves COVID can still prove a viable source of revenue. | Moderna posted $1.3 billion in third quarter revenue, vastly surpassing analyst estimates and avoiding a predicted ...

AstraZeneca may not need a major acquisition to sustain growth beyond 2030—but the British pharma is reportedly not stopping ...

The team at Evercore ISI, for its part, claimed Rasonque’s debut was nothing short of “eye-popping.” The shop is now looking at a potential $500 million in Rasonque sales for the year’s final quarter, ...

Alnylam Pharmaceuticals is seeking a new chief commercial officer as the biopharma announced that its six-year CCO veteran ...

ANI Pharmaceuticals is forking over more than half a billion dollars to broaden its rare disease business. | ANI ...

Knudsen’s departure will mark the end of a 27-year run at Novo, with Doustdar telling analysts Wednesday that the outgoing ...

Amid surging sales of Rezdiffra, Madrigal Pharmaceuticals is facing a whistleblower lawsuit alleging that senior leadership ...

Merck & Co. is chasing the finish line with its eye on one prize: a world without cancer. | In “From Our Pipeline to the ...

Vanda Pharmaceuticals’ action-packed TV ad for motion-sickness drug Nereus has irked the FDA, which accused (PDF) the company ...

Would you know the difference between a normal cold and one that has turned into something more serious? | Would you know the ...